Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1378 Views
-
Last post by frodo
-
- 0 Replies
- 1018 Views
-
Last post by frodo
-
- 0 Replies
- 2495 Views
-
Last post by NHE
-
- 0 Replies
- 1304 Views
-
Last post by frodo
-
- 0 Replies
- 1285 Views
-
Last post by frodo
-
- 0 Replies
- 1265 Views
-
Last post by frodo
-
- 0 Replies
- 1614 Views
-
Last post by NHE
-
- 0 Replies
- 479 Views
-
Last post by NHE
-
- 1 Replies
- 3078 Views
-
Last post by Tif